Biogen | BIIB - Azione





Azione Cambiamento Data
AbbVie USD 5.05B 98M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
ALKERMES USD 336.7M 140.08M 2026-03
Amgen USD 6.19B 39M 2026-03
Bayer EUR 12.34B 3M 2025-12
Biogen USD 1.95B 219.1M 2026-03
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Eli Lilly USD 14.53B 785M 2026-03
Esperion Therapeutics USD 104.21M 915K 2026-03
Gilead Sciences USD 1.91B 140M 2026-03
Incyte USD 115.62M 14.56M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 146M 7M 2026-03
Neurocrine Biosciences USD 64.5M 4.5M 2026-03
Novartis USD 6.29B 17M 2026-03
Pfizer USD 10.67B 13M 2026-03
PTC Therapeutics USD 75.57M 4.08M 2026-03
Puma Biotechnology USD 9.48M 885K 2025-09
Regeneron Pharmaceuticals USD 3.1B 97.2M 2026-03
Sanofi EUR 22.69B 1.81B 2025-12
Sanofi EUR 22.69B 1.81B 2025-12
Sarepta Therapeutics USD 1B 86.37M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Vertex Pharmaceuticals USD 1.77B 79.9M 2026-03